BioMarin Pharmaceutical Inc (BMRN) operating KPIs
BMRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 8/30145% above fair value
$58.51+1.02 (+1.77%)
Close on Oct 30, 2026Market cap $11.33BP/E 154.0Yield –
KPIs
Operating metrics that drive BioMarin Pharmaceutical's business
Coming soon
This tab will track the numbers specific to BioMarin Pharmaceutical's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.